RedChip Companies
|
Weekly Newsletter
|
|
BioVie Announces Completion of Patient Enrollment in Phase 3 Trial Assessing NE3107 in Alzheimer’s Disease
|
BioVie (Nasdaq: BIVI), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, announced that its NM101 trial evaluating NE3107 in the treatment of patients with Alzheimer’s Disease, has achieved its revised enrollment target of 400 patients. The Company anticipates announcing top line results from the study in October 2023.
For more information, visit www.bioviepharma.com
|
Unicycive to Highlight Potential of UNI-494 to Restore Mitochondrial Function and Reduce Oxidative Stress at Two Upcoming Medical and Scientific Meetings
Unicycive (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, announced that the potential of UNI-494, the Company’s proprietary drug that selectively binds to the SUR2B subunit of the mitochondrial KATP channel, will be the focus of several presentations at two upcoming medical and scientific meetings in March 2023.
|
Aptorum Group Launches NativusWell®, a Novel Nutraceutical for Menopause, in China
Aptorum Group (Nasdaq: APM), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics to tackling unmet medical needs, announced the exciting commercial launch of NativusWell, a new dietary supplement supporting women’s health throughout the Menopausal cycles targeting the China market. NativusWell has commenced collaboration with one of the largest e-commerce platforms in China, JD.com, and NativusWell is now distributable in China via JD.
|
|
|
Sidus Space to Integrate Edge Artificial Intelligence (Edge AI) Technology in Planned Satellite Constellation
Sidus Space (Nasdaq: SIDU), a Space-as-a-Service satellite company focused on commercial satellite design, manufacture, launch, and space-based data collection, announced integration of edge AI capabilities into its planned satellite constellation. The combination of a rapid revisit rate satellite constellation and onboard high performance edge AI computing is expected to enable Sidus to offer industry leading data transmission speed.
|
Nutriband COO Alan Smith Ph.D. Selected for FDA Center for Research on Complex Generics Stakeholder Expert Committee
Nutriband (Nasdaq: NTRB) announced that Alan Smith, Ph.D., Chief Operating Officer (COO), Nutriband, and President of its subsidiary, 4P Therapeutics LLC ("4P Therapeutics"), has been selected for the FDA's Center for Research on Complex Generics Stakeholder Expert Committee on Adhesion Testing for Transdermal/Topical Delivery Systems.
|
|
|
Upcoming Events |
|
|
|
NASDAQ: IMNM - Immunome |
4:15pm Eastern |
Immunome was founded to advance the discovery and development of antibody-based drugs. Our proprietary antibody Discovery Engine identifies novel therapeutic antibodies, and their antigen targets, by leveraging the most highly-educated components of the B cells from patients who have learned to fight off their disease. |
|
|
|
|
NASDAQ: BIVI - BioVie |
4:15pm Eastern |
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. |
|
|
|
|
NYSE American: ZOM - Zomedica |
4:15pm Eastern |
Zomedica is revolutionizing veterinary health care with a focus on addressing unmet needs through its expanding product portfolio of innovative diagnostics and medical devices designed to improve pet health as well as productivity and practice profitability for veterinarians. |
|
|
|
|
NASDAQ: ASPI - ASP Isotopes |
4:15pm Eastern |
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
|
|
NASDAQ: APM - Aptorum Group |
4:15pm Eastern |
Aptorum Group Limited (Nasdaq: APM) is a clinical stage biopharmaceutical company dedicated to developing and commercializing therapeutic assets to treat diseases with unmet medical needs. |
|
|
|
|
NASDAQ: BFRG - BullFrog AI |
4:15pm Eastern |
BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University, BullFrog AI is at the forefront of AI-driven drug development. |
|
|
|
|
OTCQB: QYOUF - QYOU Media |
4:15pm Eastern |
QYOU Media operates in India and the United States producing and distributing content created by social media stars and digital content creators. |
|
|
|
|
NASDAQ: SIDU - Sidus Space |
4:15pm Eastern |
Sidus Space Inc is a Space-as-a-Service company focused on commercial satellite design, manufacture, launch, and data collection with a vision to enable space flight heritage status for new technologies and deliver data and predictive analytics to both domestic and global customers. |
|
|
|
|
NASDAQ: IINN - Inspira Technologies |
11:00am Eastern |
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. |
|
|
|
|
OTC: EBZT - Everything Blockchain |
4:15pm Eastern |
Everything Blockchain is a development, engineering, and services company specializing in Blockchain technologies and decentralized processing. The Company works with clients to develop custom Blockchain payment solutions settled in fiat and cryptocurrencies. |
|
|
|
|
NASDAQ: STSS - Sharps Technology |
4:15pm Eastern |
Sharps Technology is a medical device company addressing global issues while engineering a safer future for healthcare providers and people everywhere through compassionate innovation. |
|
|
Archive Events |
|
|
|
NASDAQ: IINN - Inspira Technologies |
Meeting Duration 35 minutes |
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. |
|
|
|
|
NASDAQ: ASPI - ASP Isotopes |
Meeting Duration 23 minutes |
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
|
|
OTCQB: AMNI - American Noble Gas |
Meeting Duration 16 minutes |
American Noble Gas Inc is active in the energy sector. It has conducted an environmental study and developed geological information from the reprocessing and additional evaluation of existing two-dimensional (2-D) seismic data in the Perlas and Tyra concession blocks. |
|
|
|
|
NASDAQ: RCRT - Recruiter.com |
Meeting Duration 44 minutes |
Recruiter.com is an on-demand recruiting platform providing flexible talent acquisition solutions that scale from startups to the Fortune 100. |
|
|
|
|
NYSE American: GNS - Genius Group |
Meeting Duration 74 minutes |
Genius Group is a world leading entrepreneur Edtech and education group, with a mission to disrupt the current education model with a student-centered, life-long learning curriculum that prepares students with the leadership, entrepreneurial and life skills to succeed in today’s market. |
|
|
|
|
NASDAQ: KWE - KWESST Micro Systems |
Meeting Duration 38 minutes |
KWESST Micro Systems develops and commercializes breakthrough next-generation tactical systems that meet the requirements of security forces and personal defense for overmatch capability against adversaries. |
|
|
|
|
NASDAQ: GENE - Genetic Technologies Limited |
Meeting Duration 28 minutes |
Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health. |
|
|
|
|
NASDAQ: ARDS - Aridis Pharmaceuticals |
Meeting Duration 62 minutes |
Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics. |
|
|
|
|
NASDAQ: BIVI - BioVie |
Meeting Duration 46 minutes |
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. |
|
|
|
|
OTC: EBZT - Everything Blockchain |
Meeting Duration 37 minutes |
Everything Blockchain is a development, engineering, and services company specializing in Blockchain technologies and decentralized processing. The Company works with clients to develop custom Blockchain payment solutions settled in fiat and cryptocurrencies. |
|
|
|
|
NASDAQ: RVPH - Reviva Pharmaceutical |
Meeting Duration 46 minutes |
Reviva is a Phase 3 clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families. |
|
|
Lesson of the Week
Map your course for success with small-caps.
|
|
|
MidSouth Week in Review
Lingering inflation and fears of higher interest rates caused the yield on the 5-year Treasury bonds to rise to 4.3% and the 30-year bond yields to hit 4%.
|
|
|
You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2023. All rights reserved.
|
© 2023 RedChip , All rights reserved
|
|
|
|
|